We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.23% | 480.00 | 460.00 | 480.00 | 470.00 | 465.00 | 465.00 | 33,518 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.95 | 222.78M |
TIDMTSTL
RNS Number : 3213V
Tristel PLC
02 November 2017
Tristel plc
("Tristel" or "the Company")
Directors dealing/grant of options
Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products, intends, subject to shareholder approval, to implement a Performance Share Plan to commence in 2018 (the "2018 Scheme").
Paul Swinney (CEO), Elizabeth Dixon (Finance Director), Paul Barnes (Non-Executive Director), and David Orr (Non-Executive Director) will be eligible to participate in the Scheme. These individuals will be granted options over an aggregate of 990,000 ordinary shares and the exercise price will be 1 penny. This proposal will be presented as an Ordinary Resolution to the Company's Annual General Meeting. This is to be held at 10am on 12 December 2017 at the Company's headquarters in Snailwell, Suffolk.
Background
In August 2015, ten members of Tristel's management team, including Paul Swinney and Elizabeth Dixon, participated in the Tristel plc Performance Share Plan 2015 (the "2015 Scheme"). The 2015 Scheme granted an aggregate of 1,201,017 options with a 1 penny exercise price to the participants. On 4 August 2015, the date the 2015 Scheme was announced, the Company's share price was 96 pence. The objectives of the 2015 Scheme were to grow the Company's profits and share price over the three-year period to June 2018. The vesting conditions were linked to certain profit objectives being met, or the share price of the Company being equal to or greater than 134 pence for a period of 30 consecutive dealing days. The latter condition was achieved on 6 January 2016, and the options vested on that date.
As at 1 November2017, 984,635 of the options vested under the 2015 Scheme remain unexercised which includes those held by Paul Swinney and Elizabeth Dixon.
Between 4 August 2015 and 1 November 2017, the Company's share price has increased from 96 pence to 275 pence, and the Company's market capitalisation has increased from GBP40 million to GBP118 million. The Board considers that the 2015 Scheme has successfully met its objectives.
The 2018 Scheme
The 2018 Scheme will be put forward for approval by shareholders at the Company's Annual General Meeting. If the 2018 Scheme is approved 990,000 share options will be granted on 1 January 2018 as follows:
-- Paul Swinney 500,000 options; -- Elizabeth Dixon 400,000 options; -- Paul Barnes 45,000 options; -- David Orr 45,000 options.
The options will be exercisable at 1 penny per share and will vest in three equal tranches as follows:
-- One-third will vest upon the achievement of a share price of GBP3.50; -- One-third will vest upon the achievement of a share price of GBP4.25; -- One-third will vest upon the achievement of a share price of GBP5.00.
To vest, the average share price of Tristel plc must be above the hurdle rate for a minimum three-month period
In the event of a change of control of the Company all options will vest. Any vested but unexercised options will expire on 30 June 2021. As an additional condition, the options will only be exercisable if the holder commits to hold the resulting ordinary shares until 30 June 2021 or, if sooner, until a change of control of the Company occurs.
Following the award, the equity interests of the directors being granted options will be:
Ordinary Options Options Total options Percentage shares over ordinary over ordinary held post interest currently shares currently shares proposed grant in fully held held diluted share capital -------------- ----------- ------------------ ----------------- -------------- --------------- Paul Swinney 483,129 1,156,679 500,000 1,656,679 4.6% -------------- ----------- ------------------ ----------------- -------------- --------------- Elizabeth Dixon 45,000 449,888 400,000 849,888 1.9% -------------- ----------- ------------------ ----------------- -------------- --------------- Paul Barnes 590,180 87,500 45,000 132,500 1.5% -------------- ----------- ------------------ ----------------- -------------- --------------- David Orr 12,511 - 45,000 45,000 0.1% -------------- ----------- ------------------ ----------------- -------------- ---------------
If the 2018 Scheme is approved, the aggregate number of options outstanding will be 4,020,585, representing 9.4% of the Company's existing issued share capital.
For further information please contact:
Tristel plc Tel: 01638 721 500 Paul Swinney, Chief Executive Officer Liz Dixon, Finance Director Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303 finnCap Tel: 020 7220 0500 Geoff Nash/ Giles Rolls (Corporate Finance) Alice Lane (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDFLFBDFFLFBE
(END) Dow Jones Newswires
November 02, 2017 03:00 ET (07:00 GMT)
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions